Description
+ Include: 36 videos, size: 2.43 GB
+ Target Audience: oncologist
+ Sample video: contact me for sample video
+ Information:
This 3-day conference is designed for medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician assistants (PA), advanced registered nurse practitioners (ARNP), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of review standard of care and new developments in cancer management. Residents in training and fellows from these specialties are encouraged to attend.
Topics in solid tumors and hematological malignancies will be reviewed and will include topics in breast cancer, lung cancer, gastrointestinal (GI) malignancies, gynecologic malignancies, genitourinary (GU) cancers, head and neck cancers, melanoma, and hematological malignancies such as multiple myeloma, CLL and non-Hodgkin’s lymphoma. There will also be a special session devoted to toxicity profiles, supportive care, and challenges in cancer therapy.
The areas of focus for this conference will include the current standards of care in the treatment of the aforementioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic, antiangiogenic, and immunotherapeutic agents.
Presentations from the latest national (AACR, ASCO, SABC, and ASH) and international forums (ESMO and WCLC) meetings will be discussed and guidelines of cancer care using a team approach will be emphasized. The participants in the conference will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care using a team approach but also engage in personal interaction with our panel of experts in these subjects during the questions and answers sessions.
+ Topics:
Acute Myeloid Leukemia.mp4
ADC in Breast Cancer Management.mp4
ALK & ROS-1 First Line & Mechanism of Resistance.mp4
Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents.mp4
Bispecific Antibodies in Cancer Care Actual Reality and Future Projections.mp4
Cancer and Thrombosis State-of-the-Art Management.mp4
CAR-T Cell as Strategy for the Management of Hematologic Malignancies.mp4
Chronic Lymphocytic Leukemia.mp4
Colorectal Cancer Chemotherapy Combinations Targeted Therapy and Immunotherapy.mp4
Cost of Medications How to Make Them Affordable Are We on the Right Direction.mp4
DLBCL & Hodgkin’s Disease.mp4
Early Stage TNBC Reviewing Different Strategies and Management.mp4
EGFR PKI Resistance and K-RAS Mutations.mp4
Endocrine Therapy for Early-Stage Breast Cancer Who Needs More.mp4
Favoring The Adjuvant Concept.mp4
Favoring The Neoadjuvant Concept.mp4
Follicular, Marginal Zone and Mantle Cell NHL Novel Advances.mp4
Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs).mp4
Management of Melanoma Early and Advanced Stages.mp4
Management of Metastatic Disease Using Interventional Radiology in 2023 Y90 SirSpheres and Other Procedures.mp4
Most Common Adverse Events of Checkpoint Inhibitors Current Recommendations and Management.mp4
Multiple Myeloma Triplet Quadruplet What is The Best Frontline Therapy and Next Line after First Relapse.mp4
New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer.mp4
New Developments in Sarcoma Therapy.mp4
Novel Advances in H&N and Thyroid Cancers.mp4
Novel Advances in Radiation Oncology Beyond SRS and Proton Therapy What Is Next.mp4
Novel Advances in the Therapy of Kidney and Bladder Carcinomas.mp4
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy.mp4
Novel Targets HER-2, NRG1, TROP2, CEACAM5 & HER-3.mp4
Oncology Payments Models Where Are We Going.mp4
Ovarian-Uterine & Fallopian Tube Carcinomas.mp4
Pain Management in Cancer Patients.mp4
Pancreas and Biliary Carcinomas Novel Advances.mp4
Stage IIIA-B-C NSCLC Does The PACIFIC Data Fit All-in-One.mp4
What After Immunotherapy Failure in First Line Is There Hope.mp4
What Have We Learned from the Use Of Medical Marijuana Myths and Facts.mp4
Reviews
There are no reviews yet.